Developed countries have largely achieved universal healthcare coverage, while many developing countries are implementing steps to increase coverage. While the objective is the same, healthcare systems and policies differ across countries leading to different levels of access to medicines. To understand which systems and policies can lead to better access, we must first evaluate how well countries do in terms of providing access to medicine for their populations. In this paper, we develop a Country Access to Medicines Index (CAMI) that compares and ranks countries on access to medicine outcomes. This index is based on five pillarsease of accessibility to healthcare workers and facilities, awareness of disease diagnosis and treatment, availability of medicines, affordability of medicines and adherence to right treatment. We identify key variables in each of these pillars and compare and rank 31 countries making up approximately 70% of the world's population on each of these variables, at an aggregate level on each pillar, and overall. We draw upon IMS data as well as international and country level sources to obtain the data needed for the measures. Based on weighted scores across the five pillars, we find that overall Germany and Switzerland are the highest ranked on the CAMI, while Vietnam and Morocco are ranked the lowest. 
Given this variation, it is important to understand which policies enable better access to medicine, so countries can learn from each other and improve their policies. To do this, we must first understand how well countries do in providing access to medicines. While the ATM Foundation 1 compares and ranks how pharmaceutical companies do in providing access to their medicines, there is to date, no systematic analysis that compares how well countries do in providing access to medicine. This study is the first step to fill this gap.
OBJECTIVES
The objectives of this study are as follows:
• Identify metrics to assess how countries do in providing access to medicines • Evaluate how well countries do on the identified metrics • Create a consolidated Country Access to Medicine Index (CAMI) that shows how countries compare to each other in providing access to medicines
METHODOLOGY
The CAMI is based on five pillars: ease of accessibility to healthcare workers and facilities, awareness of disease diagnosis and treatment, availability of medicines, affordability of medicines, and finally adherence to treatment. We have identified key metrics in each of these pillars and have compared and ranked 31 countries making up approximately 70% of the world's population on each of these variables, at an aggregate level on each pillar, and overall. Metric data has been drawn from various sources including IMS data as well as international and country level sources. The pillars and associated metrics are described in Table 1 .
We have weighted these pillars based on our assessment of which are more critical for access. We accord the highest weight to accessibility, since without access to health facilities and doctors, patients cannot be diagnosed, let alone be provided the treatment. Without such diagnosis, there is also no demand for better access to medicines. We have accorded second highest weight to affordability, which includes health insurance coverage. We believe this is critical as without such coverage, most patients will not be able to afford the growing number of chronic and expensive treatments. The other pillars are weighted equally.
The metrics have been selected based on how well they represent each pillar, where data was available more widely, and avoiding duplication. Calculations on each metric were normalised to create a consolidated index across metrics and pillars. Where data gaps remained for any country on any metric, we assigned numbers based on the data on the most representative set of countries.
Countries are ranked on the CAMI based on their overall score consolidated from their weighted scores on each of the five pillars. Scores are calculated on a relative scale, where 5 is the highest score and 0 is the lowest score. The results of the evaluation are presented below. Figure 1 presents the countries in descending order of how well they do on the CAMI. This is the first step in understanding how well countries do in providing access to medicine. This evaluation can be improved in the following ways:
• Data gaps on existing metrics need to be filled • New metrics need to be incorporated that capture aspects not covered in the current evaluation, such as access to specialist care, geographic distribution of facilities and equitability of access Some of this gap filling will require primary research in these markets. This can also be complemented with a survey of a representative mix of the population in each market to look at the actual clinical outcomes of access. A second future step would be to look at the relationship between performance on the index and component pillars and health outcomes. This will ensure the robustness of the CAMI by identifying which pillars and metrics matter more than others.
Finally, the CAMI can be compared against the policies pursued by different governments to see which policies work and which do not. Along with understanding the relationship between CAMI and health outcomes, this can help policy makers identify the policies that work best to not only improve access to medicine but also improve healthcare for their populations in their countries. 
